Document:

<PAGE>

                                                                  Exhibit 10.12

                         PRESCRIPTION PHARMACEUTICALS
                    INTERNET FULFILLMENT SERVICES AGREEMENT

This Internet Fulfillment Services Agreement ("Agreement") is made as of August
18, 1999, by and between Medi-Mail, Inc., a Nevada corporation ("MM"), and
more.com, Inc., a Delaware corporation ("IR").

                                   RECITALS

A.   IR is an Internet retailer and has created a marketing and sales program
designed to supply pharmaceutical products and related services to individuals
utilizing an Internet web site;

B.   MM is a licensed mail-order pharmacy providing certain prescription
pharmaceutical drugs and related products ("Products") to consumers across the
United States;

C.   IR wishes to contract with a fulfillment service provider to dispense the
Products and provide related services, including pharmacist counseling about
medication as needed, to IR's consumers in the United States;

D.   MM wishes to provide the services described herein to IR; and

E.   The parties wish to enter into this Agreement in order to set forth their
obligations to each other.

     NOW THEREFORE, in consideration of the mutual covenants and agreements set
forth in this Agreement, the parties agree as follows:

1.   TERMS AND CONDITIONS.

     Terms and conditions in Exhibit 1 as modified by Exhibit 2 (collectively,
                             ---------                ---------
"Terms and Conditions") are incorporated by this reference.  Capitalized terms
used without definition have meanings in the Terms and Conditions.  All
references to BBDC in Exhibit 1 will mean MM for purposes of this Agreement.
                      ---------

2.   PRODUCTS.

     A list of Products maintained by MM has been provided to IR for IR's
initial selection, which selection may be revised by IR from time to time as
provided in this Agreement.  MM will, from time to time, update the specific
products to be included as Products under this Agreement.  MM may add or delete
available Products upon ten (10) days' prior written notice to IR; provided,
however, IR may elect not to offer added Products, in which case any deleted
product will no longer be considered a Product.

3.   TERM.

     Subject to Sections 9 and 10 of the Terms and Conditions, the Term of this
Agreement will be until June 30, 2009.

4.   FEES.

     In addition to payment for Products, IR will pay MM the following service
fees for MM's

                                       1
<PAGE>

fulfillment services, including dispensing Products and providing pharmacist
counseling about medication as needed and other related services to IR's
consumers pursuant to this Agreement.

     4.1  Dispensing Fees.  [**]

     4.2  Favorable Pricing.  [**]

     4.3  Third Party Payer Pricing. [**]

     4.4  Niche Products Storage Fee.  At IR's reasonable request, MM will
provide storage space for additional items not generally stocked by MM ("Niche
Products"), subject to available suitable warehouse space and terms.

     4.5  Early Termination Fee.  In addition to the provisions of Section 10 of
the Terms and Conditions, IR may terminate this Agreement during the Term
without cause effective upon sixty (60) days prior written notice to MM and
payment of an early termination fee with such notice in the amount set forth
below.

          [**]

5.   SERVICE LEVELS.

     In dispensing prescriptions under this Agreement, MM will comply with the
service levels in Exhibit A.  Those service levels associated with pharmacy
                  ---------
operations (but not other customer service) will be deemed a material term of
this Agreement and any failure to comply with them will entitle IR to suspend
the exclusivity provisions under Section 1.4 of the Terms and Conditions.  Final
service levels will be adopted by the parties within ninety (90) days after MM's
call center system is enhanced and programmed for interactive voice response
capability (IVR) and such function is tested, for call center service levels;
within ninety (90) days after MM's

                                              **Confidential treatment has been
                                              requested with respect to the
                                              information contained within the
                                              "[**]" markings. Such marked
                                              portions have been omitted from
                                              this filing and have been filed
                                              separately with the Securities and
                                              Exchange Commission.

                                       2
<PAGE>

Pfastship shipping system is operation, integrated and tested, for shipping
service levels; and within sixty (60) days after MM's HBS system is operational
and implementation has been fully tested, for drug furnishing irregularity
service levels.

6.   ACCESS TO MM'S PAYERS.

     IR does not have access to MM's payers and/or third-party plans outside the
scope of the PlusCare network.

7.   AUDIT AND INSPECTION.

     During the Term, upon reasonable prior notice and during normal business
hours, each party will be entitled to audit and inspect those relevant records
maintained by the other in direct connection with its performance under this
Agreement.

8.   VIPPS CERTIFICATION.

     MM will assist IR at IR's expense in obtaining its VIPPS certification from
the National Association of Boards of Pharmacy.

9.   TOLL-FREE TELEPHONE LINES.

     MM will provide a toll-free telephone line for IR consumers, which will be
a direct pass through expense to IR billed on a monthly basis.  Consumer calls
will be answered with an IR greeting.

10.  PHARMACY AND CUSTOMER SERVICE SUPPORT.

     If any of IR's consumers require pharmacist counseling in connection with
any Products, MM will provide such services to each such consumer from Monday
through Friday, 7:00 a.m. through 5:00 p.m. (Pacific Time). MM will also provide
customer service from Monday through Friday, 6:00 a.m. through 5:00 p.m.
(Pacific Time) to respond to inquiries from IR consumers. IR may, at its sole
discretion, determine to contract with MM to hire additional pharmacists or
personnel on staff to provide additional functions or to provide similar
functions during expanded hours and days. [**]

11.  COLLATERAL MATERIAL.

     IR will also be permitted to include in each shipment up to two (2) pieces
of advertising materials, coupons or other promotional materials ("Collateral
Materials") that are printed material no bigger than 8 1/2 inches by 11 inches,
each at no additional charge so long as such Collateral Materials are to be
included in all IR shipments.  Order-specific Collateral Materials, or
Collateral Materials in excess of, or exceeding the dimensions of, the allowable
pieces of Collateral Materials described above will be subject to additional
charges to be agreed upon by the parties.  All Collateral Materials described
above will be paid for by IR.

12.  NOTICES.

Subject to Section 17.19 of the Terms and Conditions, notices to IR under this
Agreement will be

                                              **Confidential treatment has been
                                              requested with respect to the
                                              information contained within the
                                              "[**]" markings. Such marked
                                              portions have been omitted from
                                              this filing and have been filed
                                              separately with the Securities and
                                              Exchange Commission.

                                       3
<PAGE>

sent to:

                        more.com, Inc.
                        520 Third Street, Suite 245
                        San Francisco, California 94107
                        Attn: Brad Oberwager
                        Fax:  (415) 979-9598

     with a copy to:    Howard, Rice et al.
                        3 Embarcadero Center, 7/th/ Floor
                        San Francisco, California 94111
                        Attn: Ronald Star, Esq.
                        Fax:  (415) 217-5910

13.  EXHIBITS.

     All exhibits to this Agreement listed below are incorporated by this
reference.

          Exhibit Number    Exhibit Name

          1                 Terms and Conditions
          2                 Prescription Pharmaceuticals Addendum
          A                 Service Levels

     IN WITNESS WHEREOF, the parties have executed this Internet Fulfillment
Services Agreement as of the date first written above.

                            IR:  more.com, Inc.

                            By: /s/ Laureen De Buono
                            Name: Laureen De Buono
                            Title: CFO

                            MM:
                            Medi-Mail, Inc.

                            By:/s/ Carol E. Scherman
                            Name: Carol E. Scherman
                            Title: Chief Executive Officer

                                       4
<PAGE>

                                   EXHIBIT 1
                                      TO
                         PRESCRIPTION PHARMACEUTICALS
                    INTERNET FULFILLMENT SERVICES AGREEMENT
                             TERMS AND CONDITIONS

1.   PRODUCTS AND TERRITORY.

     1.1  Products.  A list of the categories of the Products ("Product
          --------
Categories") is set forth in Schedule 1.1.  BBDC will provide IR a list of
                             ------------
specific products ("Products") and related information ("Item Catalog
Information" [EDI 832 Transaction Set]) from time to time.  BBDC may add or
delete available Products upon two (2) days' notice to IR; provided, however, IR
may elect not to offer added Products.

     1.2  Niche Products.  BBDC may elect to store and ship additional products
          --------------
requested by IR, including private label products and other products that BBDC
does not otherwise carry, upon payment of the Niche Product fees set forth on
the cover page.

     1.3  Territory.  BBDC will provide fulfillment services for the Products in
          ---------
the Unites States of America and its territories and possessions and each other
territory listed on Schedule 1.3 ("Territory").  In no event will BBDC provide
                    ------------
or ship Products to IR's consumers outside the Territory.

     1.4  Exclusivity. [Omitted]
          -----------

     1.5  Right of First Refusal. [Omitted]
          ----------------------

2.  ORDERS; SHIPPING; RETURNS.

     2.1  Operations Manual.  The Operations Manual in Schedule 2.1 ("Operations
          -----------------                            ------------
Manual") is incorporated by this reference.

     2.2  Orders.  Orders for Products will be initially placed by IR's
          ------
consumers using IR's Internet web site.  IR will forward all orders for Products
to BBDC by electronic data interchange ("EDI") pursuant to Section 3.8 at least
four (4) times per day ("Orders").  Orders will set forth a description of the
Products, SKU designations, quantities, requested method of delivery, the
designated delivery locations and other required information as agreed upon by
the parties from time to time.

     2.3  Inventory.  Subject to Section 4.2, BBDC will maintain sufficient
          ---------
inventory of the Products in an effort to facilitate the delivery of all Orders
for the Products.  Inquiries by IR to BBDC's customer service representatives
concerning any Products must reference BBDC's Product number.

     2.4  Shipping.  BBDC will cause all lawful Orders to be shipped in
          --------
accordance with the Operations Manual. Shipping guidelines may change due to
legal and product shipping requirements. Certain Products may be subject to
special shipping and handling fees. Title to, and risk of loss of, all Products
will pass from BBDC to IR upon BBDC's delivery of the Products to the shipper
for delivery to IR's consumer. [**] will use commercially reasonable efforts to
ensure that all Orders for Products received before the daily "cut-off time"
will be shipped by the corresponding shipping time for such day. Out-of-stock or
back-ordered Products will be shipped promptly after BBDC's receipt of such
Products from the manufacturer or other supplier. Inquiries about shipping
status will be first directed to the shipper and any such initial inquires to
BBDC's customer service representatives where BBDC has provided IR with a
shipper's tracking number will be subject to an additional charge. BBDC will not
process any of the following shipments of Products: (i) international shipments,
(ii) COD shipments, (iii) shipments requiring a declared value, (iv) shipments
to freight

                                              **Confidential treatment has been
                                              requested with respect to the
                                              information contained within the
                                              "[**]" markings. Such marked
                                              portions have been omitted from
                                              this filing and have been filed
                                              separately with the Securities and
                                              Exchange Commission.

                                       5
<PAGE>

forwarding agents, (v) shipments of hazardous materials or other products
requiring specialized shipping that shipper and/or BBDC are not prepared to
provide, and (vi) Drug Enforcement Administration ("DEA") Schedule II controlled
substances.

     2.5  Labels and Invoices.  Unless modified by Exhibit 2, if any, IR will
          -------------------                      ---------
provide BBDC standard packaging (standard size cardboard boxes, plain colored
plastic tape and plain bubble/paper packing material), labels and invoice forms
bearing IR's, and not BBDC's, name, logo and telephone number for BBDC's use in
shipping Products. IR may select from BBDC's standard invoice formats (inserting
IR's logo and return address) at no additional charge. Modifications and custom
work is subject to an additional charge at BBDC's then-current rates. If IR's
standard packaging, labels and invoice forms are not ordered through BBDC's
designated vendor (or IR uses non-standard packaging, labels or forms), IR will
be subject to additional charges for handling, storage and administration.

     2.6  Returns.  The Returned Goods Policy in Schedule 2.6 is incorporated by
          -------                                ------------
this reference.

3.  PRICING; PAYMENT.

     3.1  Pricing and Fees.  [**]
          ----------------

     3.2  Price Adjustments.  BBDC may change the pricing of any Product at any
          -----------------
time; provided, however, any such change will not be effective with respect to
Products ordered by IR's consumers within twenty-four (24) hours of BBDC's
electronic notice to IR.

     3.3  Rebates.  [**]
          -------

     3.4  Taxes.  IR will obtain and maintain a resale tax certificate in
          -----
Kentucky and each other jurisdiction in which BBDC delivers Products to IR's
shipper.  IR will collect and remit all applicable sales taxes and other taxes
on the sale or provision of Products to IR's consumers.  IR will be responsible
for and will pay any excise, sales or use tax or other similar charge in the
nature of a tax imposed with respect to transactions under this Agreement (other
than income or other taxes on BBDC's net income) and, if paid or required to be
paid by BBDC, such amount will be added to and become part of the amount payable
by IR.

     3.5  Timing of Payment.  BBDC will submit invoices for the Products to IR
          -----------------
on a per-Order basis for each Order received from IR's consumer. [**] IR's
obligation to pay for all purchases invoiced will be absolute and unconditional
and will not be subject to any abatement, reduction, set-off, defense,
counterclaim, interruption, deferment or recoupment for any reason whatsoever,
and such payments will be and continue to be payable in all events.

     3.6  Late Payment.  If payment is not received as described in Section 3.5,
          ------------
a late payment penalty of the lower of [**]

                                              **Confidential treatment has been
                                              requested with respect to the
                                              information contained within the
                                              "[**]" markings. Such marked
                                              portions have been omitted from
                                              this filing and have been filed
                                              separately with the Securities and
                                              Exchange Commission.

                                       6
<PAGE>

[**]. The right of BBDC to assess penalties for IR's payment delays will not
relieve IR of its obligation to make prompt payment in accordance with this
Section 3.

     3.7  Financial Reconciliation.  The Financial Reconciliation Process in
          ------------------------
Schedule 3.7 ("Financial Reconciliation Process") is incorporated by this
------------
reference.

     3.8  EDI/EFT.  The EDI/EFT Agreement in Schedule 3.8 is incorporated by
          -------                            ------------
this reference.  All Orders, IR sales reports, BBDC invoices and remittance
detail information will be transmitted by EDI.  All funds will be transferred
between the parties by electronic funds transfers ("EFT").  All data files
transmitted over the public Internet will be encrypted in adherence with EDIINT
standards.

4.   IR'S COVENANTS.

     4.1  Web Site.  IR will, at its cost, develop, produce, implement and test
          --------
its web site and supporting electronic commerce enabling software, as well as
provide technical support, including developing and procuring credit card
processing and encryption software, subject, however, to the reasonable approval
of BBDC in relation to its fulfillment responsibilities under this Agreement.
In addition, IR will, at its cost, develop and procure all software interfaces
or programs necessary to enable IR to connect with BBDC's systems and operations
facilities.  All software and hardware developed or purchased by IR to support
BBDC under this Agreement will remain the property of IR.  Each screen
accessible to consumers on IR's web site will clearly identify IR.  Unless
modified by Exhibit 2, if any, no content on IR's web site will directly or
            ---------
indirectly (a) identify BBDC or (b) lead any consumer or potential consumer to
believe that IR or its web site is the manufacturer of a Product.  IR will
update its web site to indicate that a Product is unavailable or subject to
other special conditions based upon BBDC's Product notices and any failure to do
so that results in additional handling, storage, administrative or other costs
to BBDC will subject IR to an additional charge.

     4.2  Marketing. [**].  BBDC acknowledges that IR has sole authority and
          ---------
control over each stage of marketing for its program; provided however, if IR is
prohibited by law from performing any contemplated marketing activities, BBDC
may perform such functions at IR's expense to the extent BBDC may lawfully do
so. IR will provide reasonable advance notice of special offers, such as bundled
items, featured items and sales, advertising campaigns and other events that can
be reasonably expected to generate unusual volume (either overall or for
specific Products) in order to allow BBDC to have adequate inventory, staff and
other resources available to handle such volume.

     4.3  Consumer Enrollment.  IR will have sole responsibility for soliciting
          -------------------
orders from consumers under this Agreement.

     4.4  Records.  IR will retain all documentation required by federal and
          -------
state statutes and regulations.

     4.5  License Revocation.  IR will inform BBDC in writing within three (3)
          ------------------
business days after receiving notice of any action or proceeding from any
federal, state, or local agency to restrict, suspend, or revoke any of IR's
required licenses, permits or registrations or any other approval required to
supply the services described in this Agreement.

     4.6  Compliance with Law.  IR will perform all of its duties under this
          -------------------
Agreement in full compliance with all applicable federal, state, and local laws
and regulations.

     4.7  Adequate Space and Personnel.  IR represents and warrants it has, and
          ----------------------------
agrees that it will continue to maintain or enlarge, as appropriate, such space,
equipment, resources, and personnel at its sole cost and expense necessary to
promote its web site and perform under this Agreement.

                                              **Confidential treatment has been
                                              requested with respect to the
                                              information contained within the
                                              "[**]" markings. Such marked
                                              portions have been omitted from
                                              this filing and have been filed
                                              separately with the Securities and
                                              Exchange Commission.

                                       7
<PAGE>

     4.8   Prohibition Against Publication of Certain Materials.  IR will not
           ----------------------------------------------------
knowingly or unknowingly incorporate in IR's web site any of the following
material (including pictures, links, or any other content, whether visible or
invisible with a web browser):

           4.8.1  any material which violates or infringes any national or
international copyright, trademark, trade secret, patent, statutory, common law
or other proprietary rights of others, including any party's privacy right or
right of publicity, in effect or which may hereafter be enacted and applicable
to this Agreement or web sites;

           4.8.2  any material that is libelous, slanderous, harmful, abusive,
threatening, obscene or pornographic; or

           4.8.3  distribution lists to be used for unsolicited electronic mail
or other mass electronic mailings.

     4.9   Adverse Event Reporting.  IR will report all adverse events relating
           -----------------------
to the Products pursuant to the requirements of the Food and Drug
Administration.

     4.10  Listed Chemicals.  IR will obtain and maintain a Listed Chemicals
           ----------------
license from the DEA and will report the sale and shipment of all Products
pursuant to the requirements of the DEA and comply with all comparable state
requirements.

     4.11  Product Recalls.  IR acknowledges and agrees that BBDC will not be
           ---------------
obligated to recall any Product which is the subject of a manufacturer or
supplier recall but that either party may elect to do so from time to time in
its sole discretion, provided that any recall undertaken by BBDC at the request
of IR will be at IR's sole cost and expense.

     4.12  Support.  BBDC and IR will jointly evaluate which party will provide
           -------
other support functions relating to the Products.

5.  BBDC'S COVENANTS.

     5.1   Records.  BBDC agrees that it will retain all documentation required
           -------
by federal and state statutes and regulations.  If and to the extent required by
Section 1395x(v) (1) of Title 42 of the United States Code, as subsequently
amended from time to time, until the expiration of four (4) years after the
termination of this Agreement, BBDC will make available upon written request to
the Secretary of the United States Department of Health and Human Services, or
upon request to the Comptroller General of the United States General Accounting
Office, or any of their duly authorized representatives, a copy of this
Agreement and such books, documents, and records as are adequate to certify the
nature and extent of the costs of the goods and services provided by BBDC under
this Agreement. BBDC further agrees that in the event BBDC carries out any of
its duties under this Agreement through a subcontract, with a value or cost of
Ten Thousand Dollars ($10,000) or more over a twelve (12) month period, with a
related organization, such contract will contain a clause to the effect that
until the expiration of four (4) years after the furnishing of such services
pursuant to such subcontract, the related organization will make available, upon
written request to the Secretary of the United States Department of Health and
Human Services, or upon request to the Comptroller General of the United States
General Accounting Office, or any of their duly authorized representatives, a
copy of such subcontract and such books, documents and records of such
organizations as are necessary to verify the nature and extent of such costs.
Notwithstanding anything set forth in this Agreement to the contrary, BBDC will
have no obligation under this Agreement to make public attorney-client
privileged documents.

     5.2   Records.  BBDC will retain all documentation required by federal and
           -------
state statutes and regulations.

                                       8
<PAGE>

     5.3   License Revocation. BBDC agrees that it will inform IR promptly after
           ------------------
receiving notice of any action or proceeding from any federal, state, or local
agency to restrict, suspend, or revoke any of BBDC's required licenses, permits
or registrations or any other approval required to supply the services described
in this Agreement.

     5.4   Compliance with Law.  BBDC agrees that it will perform all of its
           -------------------
duties under this Agreement in full compliance with all applicable federal,
state, and local laws and regulations.

     5.5   Adequate Space and Personnel.  BBDC represents and warrants it has,
           ----------------------------
and agrees that it will continue to maintain or enlarge, as appropriate, such
space, equipment, resources, and personnel at its sole cost and expense
necessary to promote its web site and perform under this Agreement.

6.  REPRESENTATIONS OF THE PARTIES.

     6.1   Representations and Warranties of BBDC.  BBDC hereby represents and
           --------------------------------------
warrants to IR that (i) it is duly organized, validly existing and in good
standing under the laws of the jurisdiction in which it was organized; (ii) the
person executing this Agreement on its behalf is duly authorized to bind it to
all terms of this Agreement; (iii) it will have good title to all Products
delivered pursuant to this Agreement (unless such Product is subject to a
chargeback agreement); (iv) except as otherwise provided, all such Products will
be free from any security interest or other lien (unless such Product is subject
to a chargeback agreement); (v) all Products will be delivered without damage to
IR's shipper for delivery to IR's consumer; (vi) this Agreement, when executed
and delivered by it, will be its legal, valid, and binding obligation,
enforceable against it in accordance with its terms; and (vii) its execution,
delivery and performance of this Agreement will not conflict with or breach its
charter documents, delegations of authority or any material agreement to which
it is a party, or require the consent of or notice to any third party or
governmental authority.

     6.2   No Representations or Warranties Regarding Products.  BBDC makes, and
           ---------------------------------------------------
will be deemed to make, no representations or warranties, express or implied,
written or oral, as to the value, absence of defect, absence of infringement, or
the absence of any obligation based on strict liability in tort, or any other
representation or warranty whatsoever, express or implied, with respect to the
Products and services provided in this Agreement. BBDC EXPRESSLY DISCLAIMS ALL
WARRANTIES, EXPRESS OR IMPLIED, WRITTEN OR ORAL, INCLUDING BUT NOT LIMITED TO
THOSE OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE REGARDING THE
PRODUCTS AND SERVICES PROVIDED IN THIS AGREEMENT. IR understands that BBDC is
not the manufacturer of any Products and agrees that IR will settle all claims,
defenses, set-offs and counterclaims it may have with or against any
manufacturer directly with the manufacturer and will not assert any such claims,
defenses, set-offs or counterclaims against BBDC. IR agrees BBDC has made no
such representations or warranties, written or oral, express or implied, about
the Products or their fitness for any purpose. Accordingly, IR agrees that BBDC,
its subsidiaries and affiliates and the directors, officers, shareholders and
agents of each will not be liable to IR for any liability, claim, loss, damage
(consequential or otherwise) or expense of any kind caused, directly or
indirectly by (i) the inadequacy of the Products for any purpose, (ii) any
deficiency or defect, (iii) any delay in providing the Products, (iv) failure to
provide the Products, or (v) death or bodily injury which may be caused by the
Products.

     6.3   Representations and Warranties of IR.  IR hereby represents and
           ------------------------------------
warrants to BBDC that (i) it is duly organized, validly existing and in good
standing under the laws of the jurisdiction in which it was organized; (ii) the
person executing this Agreement on behalf of IR is duly authorized to bind IR to
all terms of this Agreement; (iii) this Agreement, when executed and delivered
by IR, will be the legal, valid, and binding obligation of IR, enforceable
against IR in accordance with its terms; (iv) its execution, delivery and
performance of this Agreement will not conflict with or breach its charter
documents, delegations of authority or any material agreement to which it is a
party, or require the consent of or notice to any third party or governmental
authority; and (v) IR holds all valid licenses, permits and registrations in
appropriate jurisdictions to permit IR to operate its Internet services.

                                       9
<PAGE>

7.   SOFTWARE AND DATABASE LICENSE.

     7.1  Grant of License.  For BBDC's Consumer Image and Ingredient Database
          ----------------
and each software application and/or database BBDC may provide to IR, to the
extent of BBDC's legal capacity to do so, grants IR a non-exclusive,
nontransferable and revocable license for the use of such software and/or
database ("Software") and its related documentation ("Documentation") subject to
payment by IR of the applicable licensing fee established by BBDC from time to
time. Each license is granted solely during the Term. BBDC does not grant to IR
any rights to any copyright, patent, trademark, trade name or similar rights
with respect to any Software or Documentation or any other information provided
to IR by BBDC. IR will not use the name, trade name, trademarks, service marks,
trade dress, logos or other intellectual property of BBDC, Product manufacturers
or suppliers or any of BBDC's affiliates in its web site, publicity releases,
advertising, sales literature or materials, or in any similar activity without
BBDC's prior written consent.

     7.2  No Sublicense.  IR may not sublicense, lease, distribute or otherwise
          -------------
transfer Software or Documentation or IR's right to use the Software or
Documentation.

     7.3  No Copies.  IR may not make, or allow anyone else to make, copies of
          ---------
the Software or related Products, beyond one copy for backup and archival
purposes, except as BBDC may otherwise agree in writing.  IR may not remove,
obscure, or deface any proprietary notices contained in the Software or
Documentation, and IR must include such notices in any permitted copy of the
Software.

     7.4  No Alterations.  IR may not alter, modify or adapt any Software or
          --------------
Documentation or create derivative works from them.  IR may not translate,
reverse engineer, disassemble or decompile the Software.  BBDC will have no
liability for any claims by third parties or IR based upon altered Software or
Documentation.

     7.5  Termination of License.  The license to any part of the Software and
          ----------------------
Documentation will terminate automatically if IR fails to comply with the terms
of this license or any other material provision in this Agreement, or if the
Products for which IR is using the Software are discontinued.  Upon termination
of a license, IR must cease using the Software and Documentation and, at BBDC's
election, return or destroy all copies of the Software and Documentation IR may
have in its possession or under its control, and certify to BBDC that IR has
done so.  All of IR's obligations in this Agreement will survive termination of
any license.

     7.6  Disclaimer.  BBDC disclaims any representation or warranty regarding
          ----------
the Software and Documentation.  IR acknowledges the possibility that (i) the
Software may not operate in combination with other software or hardware or in
the manner IR or its consumers may select for use and (ii) Software may not
operate without interruption or be error-free.

     7.7  No Rights in Data.  All files, input materials and output materials,
          -----------------
the media upon which they are located (including cards, tapes, discs and other
storage facilities), and all Software (together with any Documentation, source
codes, object codes, upgrades, revisions, modifications and any related
materials) which are utilized by or developed for IR in connection with this
Agreement will be the property of BBDC.

     7.8  Notice of Claims; Removal of Products and Content.  Notwithstanding
          -------------------------------------------------
Section 14.2.1, IR will immediately notify BBDC of any written or oral claim
that any Software or Documentation used by IR in its web site or otherwise
infringes on the rights of any third party.  Immediately upon notice from BBDC,
IR will discontinue the offering of any Product and the use of any Software and
Documentation that BBDC determines may subject BBDC or IR to liability to any
third party.  Failure to notify BBDC in writing within three (3) business days
of the receipt of an oral or written claim that any Software or Documentation
used by IR in its web site or otherwise infringes on the rights of any third
party will terminate and rescind all of BBDC's representations, warranties, and
indemnification obligations with respect to the subject matter of the claim.

                                       10
<PAGE>

8.   [Omitted]

9.   TERM.

          Unless terminated earlier pursuant to Section 10, the term of this
Agreement will be for the period years set forth on the cover page of this
Agreement from the date of this Agreement and will be automatically extended for
additional, successive one (1) year terms (collectively, the "Term") unless
either party gives written notice to the other of its intention to not extend at
least ninety (90) days prior to the end of the then current Term.

10.  TERMINATION OF AGREEMENT.

     10.1  Default.  This Agreement may be terminated by IR by providing written
           -------
notice of termination to BBDC upon a default by BBDC under this Agreement.  This
Agreement may be terminated by BBDC by providing written notice of termination
to IR upon a default by IR under this Agreement.  For purposes of this
provision, a default will be deemed to have occurred upon the happening of any
of the following:

           10.1.1  With respect to either party (A) filing an application by
such party for, or consent to, appointment of a trustee, receiver, or custodian
of its assets; (B) entry of an order for relief in proceedings under the United
States Bankruptcy Code, as amended or superseded from time to time; (C) making a
general assignment for the benefit of creditors; (D) entry of an order by any
court of competent jurisdiction appointing a trustee, receiver, or custodian of
its assets unless the proceedings and the person appointed are dismissed within
ninety (90) days; or (E) failure generally to pay its debts as the debts become
due within the meaning of Section 303(h)(1) as amended or superseded from time
to time, of the United States Bankruptcy Code, as determined by a Bankruptcy
Court, or in the event of a party's admission in writing of its inability to pay
its debts as they become due.

           10.1.2  A party's failure to pay any amount that is due to the other
party under this Agreement or a consistent failure to make timely payments or
shipments under this Agreement and such failure continues for ten (10) days
after written notice from the other party; or

           10.1.3  A party's failure to perform any other material obligation
under this Agreement, and such failure continues for thirty (30) days after such
party receives written notice of such breach from the non-breaching party;
provided, however, if the breaching party has commenced to cure such breach
within such thirty (30) days, but such cure is not completed within the thirty
(30) days, such party will be afforded the amount of additional time reasonably
necessary to complete its cure, provided it diligently pursues doing so until
completion.

     10.2  Adverse Regulatory Changes.  In the event of a material adverse
           --------------------------
change in the laws of any jurisdiction so as to affect through increased
regulations, liability, or otherwise, BBDC's fulfillment operations or the
Internet sale of Products, then either party may terminate this Agreement upon
thirty (30) days' written notice to the other without further obligation.

     10.3  Licenses.  If any required licenses, permits or registrations of BBDC
           --------
or IR are revoked or suspended so as to materially impair such party's ability
to perform under this Agreement, BBDC or IR may terminate this Agreement upon
thirty (30) days' written notice without further obligation.

     10.4  Effect of Termination or Expiration.  Upon termination or expiration
           -----------------------------------
of this Agreement for any reason, BBDC will be entitled to payment of any
amounts owed to it by IR for Products ordered prior to termination or expiration
and shipped to IR's consumers.  The obligations of the parties described in
Sections 4, 5, 6, 7 (except the license granted thereunder), 8, 11, 12, 13, 14,
15 and 16 and any provision the context of which shows that the parties intended
the provision to survive will remain in effect notwithstanding the expiration or
termination of this Agreement. Additionally, termination of this

                                       11
<PAGE>

Agreement will have no effect upon the obligation of the parties under the terms
of any other agreements entered into between the parties, except as set forth
otherwise in such other agreements.

11.  CONFIDENTIALITY.

     11.1  "Confidential Information".  "Confidential Information" will mean any
            -------------------------
and all information disclosed in writing or orally by either party to the other
party, which is either confidential or proprietary in nature.  "Confidential
Information" will not include: (i) information that is or will become generally
available to the public through no fault of the receiving party; (ii)
information that was known to the receiving party before that party received it
under this Agreement and was free of any obligation of nondisclosure; or (iii)
information that is disclosed in good faith to the receiving party by a third
party lawfully in possession of such information and who is not under an
obligation of nondisclosure with respect to such information.

     11.2  Nondisclosure.  During the Term and for ten (10) years thereafter,
           -------------
neither party will, without the prior written consent of the other party,
disclose to any third party (unless such disclosures are required by law) or use
for its own purposes (except as contemplated by this Agreement) this Agreement
or any other Confidential Information concerning the other party's business,
operations, or products that is obtained in the course of performing this
Agreement.  Notwithstanding the foregoing, the parties may issue a joint press
release as promptly as practicable after the execution of this Agreement and may
continue to communicate with employees, customers, suppliers, lenders,
shareholders and others as may be legally required or appropriate and not
inconsistent with the best interests of the other party or the prompt
consummation of the activities contemplated by this Agreement.

     11.3  Customer Lists.  BBDC and IR will each retain ownership of its own
           --------------
customer lists.

12.  NON-SOLICITATION.

     12.1  Covenant Not to Solicit.  Each party agrees that neither it nor its
           -----------------------
employees, agents, or representatives will, during the ("Non-Solicitation
Period") without the other party's prior written consent, solicit for hire any
person who is employed by the other party or any of its subsidiaries or
affiliates

     12.2  Damages.  Because of the difficulty of measuring economic losses as a
           -------
result of the breach of any of the foregoing covenants, and because of the
immediate and irreparable damage that would be caused for which the other party
would have no other adequate remedy, each party agrees that, in the event of a
breach by it of any of the covenants set forth in this Section, the other party
or its subsidiary or affiliate may, at its option, in addition to obtaining any
other remedy or relief available to them (including damages at law), enforce the
provisions of this Section by injunction and other equitable relief.

     12.3  Reasonable Restraint.  Each party agrees that the covenants contained
           --------------------
in this Section impose a reasonable restraint in light of the other party's
activities, business and future plans.

     12.4  Severability; Reformation.  The covenants in this Section are
           -------------------------
severable and separate, and the unenforcability of any specific covenant will
not affect the provisions of any other covenant in this Section or in this
Agreement.  In the event any court of competent jurisdiction will determine that
the scope, time or territorial restrictions set forth in this Section are
unreasonable, then it is the intention of the parties that such restrictions be
enforced to the fullest extent which the court deems reasonable, and the
provisions of this Section will thereby be reformed.

     12.5  Independent Covenant.  Each of the covenants in this Section will be
           --------------------
construed as a covenant independent of any other provision of this Agreement,
and the existence of any claim or cause of action of one party against the
other, or any of its subsidiaries or affiliates, whether predicated on this
Agreement or otherwise, will not constitute a defense to the enforcement by such
party or such subsidiaries or affiliates of such covenants.

                                       12
<PAGE>

     12.6  Computation of the Non-Solicitation Period.  The Non-Solicitation
           ------------------------------------------
Period will be computed by excluding from such computation any time during which
either party is in violation of any provision of this Section and any time
during which there is pending in any court of competent jurisdiction any action
(including any appeal from any judgment) in which a party seeks to enforce the
covenants contained in this Section or in which the other party contests the
validity or enforceability of any such covenant or seeks to avoid the
performance or enforcement of any such covenant.

     12.7  Materiality.  Each party acknowledges and agrees that the covenants
           -----------
set forth in this Section are a material and substantial part of this Agreement.

13.  INSURANCE.

     During the Term and for two (2) years thereafter, IR will maintain at its
own cost and expense the following insurance together with such other insurance
as reasonably requested by BBDC in light of experience and changing risk
exposure:

     (a)   Commercial General Liability Insurance covering its premises,
including bodily injury, property damage, broad form contractual liability,
independent contractors and products liability/completed operations coverages,
with limits of not less than [**] per occurrence and [**] aggregate or [**]
single limit.

     (b)   Workers' Compensation Insurance as mandated or allowed by all states
in which IR's business is being performed, including at least [**] coverage for
Employer's Liability.

     (c)   All Risk Property Insurance in an amount adequate to cover the cost
of replacement of all equipment, improvements, and betterments at IR locations
in the event of loss or damage.

     (d)   Errors and Omissions Insurance in the amount of [**], naming BBDC as
an additional insured.

     All such policies will be written by a carrier or carriers rated "A" or
above by Best, will contain a clause requiring the carrier to give BBDC at least
thirty (30) days' prior written notice of any material change or cancellation of
coverage for any reason, and simultaneously with IR's execution of this
Agreement and annually thereafter, IR will deliver to BBDC original Certificates
of Insurance evidencing coverage required by this Section.

14.  INDEMNIFICATION.

     14.1  Indemnification by IR.  IR will indemnify, defend, and hold harmless
           ---------------------
BBDC and its officers, directors, agents and affiliates from and against any and
all claims, demands, actions, causes of action, losses, judgments, damages,
costs and expenses (including, but not limited to, attorneys' fees, court costs,
and costs of settlement) ("Claim") to the extent arising out of claims against
BBDC for:  (1) the death of, or bodily injury to, any person on account of the
use of a Product that results from IR's sale of such Product; or (2) any breach
by IR of any of its representations, warranties or covenants in this Agreement.

           14.1.1  Notice by BBDC. Upon receipt of any notice of a Claim, BBDC
                   --------------
will promptly notify IR in writing of any such Claim; provided, however, any
failure to so notify IR will not relieve BBDC of any liability it may have to IR
except to the extent such liability was caused by such failure.

           14.1.2  Retention of Counsel. IR will retain counsel at its expense
                   --------------------
to act as lead counsel in the defense of all Claims against BBDC. The
Indemnified Party may retain counsel. BBDC may retain counsel of its own choice
at BBDC's expense to the extent necessary to protect BBDC's interests and to act
as co-counsel in the litigation or settlement of any Claim or threatened Claim.
So long as IR does not enter into any settlement agreement or consent judgment
that admits liability on the part of BBDC or that

                                              **Confidential treatment has been
                                              requested with respect to the
                                              information contained within the
                                              "[**]" markings. Such marked
                                              portions have been omitted from
                                              this filing and have been filed
                                              separately with the Securities and
                                              Exchange Commission.

                                       13
<PAGE>

fails to include an unconditional release of BBDC from all liability from all
asserted or threatened Claims, IR will have the right to control the defense,
settlement, and prosecution of any litigation.

     14.2  Indemnification by BBDC.  BBDC will indemnify, defend, and hold
           -----------------------
harmless IR and its officers and directors from and against any and all Claims
to the extent arising out of claims against IR for:  (1) the dishonest,
fraudulent, negligent, willful, or criminal acts of BBDC or BBDC's employees,
agents, or representatives acting alone or in collusion with others; or (2) any
breach by BBDC of any of its representations, warranties or covenants in this
Agreement.

           14.2.1  Notice by IR.  Upon receipt of any notice of a Claim, IR will
                   ------------
promptly notify BBDC in writing of any such claim; provided, however, any
failure to so notify BBDC will not relieve IR of any liability it may have to
BBDC except to the extent such liability was caused by such failure or as
provided in Section 7.8.

           14.2.2  Retention of Counsel. BBDC will retain counsel at its expense
                   --------------------
to act as lead counsel in the defense of all Claims against IR. IR may retain
counsel of its own choice at IR's expense to the extent necessary to protect
IR's interests and to act as co-counsel in the litigation or settlement of any
Claim or threatened Claim. So long as BBDC does not enter into any settlement
agreement or consent judgment that admits liability on the part of IR or that
fails to include an unconditional release of IR from all liability from all
asserted or threatened Claims, BBDC will have the right to control the defense,
settlement, and prosecution of any litigation.

15.  LIMIT ON LIABILITY.

           NEITHER PARTY WILL BE LIABLE FOR ANY CLAIM ARISING OUT OF THIS
AGREEMENT FOR INDIRECT, CONSEQUENTIAL, SPECIAL, OR PUNITIVE DAMAGES, WHETHER OR
NOT IT KNEW OR HAD REASON TO KNOW OF THE POSSIBILITY OF SUCH DAMAGES AND, EXCEPT
FOR PAYMENT OF MONEY DUE UNDER THIS AGREEMENT AND EXCEPT AS PROVIDED IN SECTION
14.1 OR SECTION 14.2, NEITHER PARTY'S AGGREGATE LIABILITY TO THE OTHER UNDER
THIS AGREEMENT FOR ANY AND ALL CLAIMS, WHETHER IN CONTRACT, TORT, OR OTHERWISE,
WILL EXCEED $1,000,000.

16.  INDEPENDENT CONTRACTOR.

           Each party is an independent contractor and is solely responsible for
all taxes, withholdings, and other similar statutory obligations, including, but
not limited to, workers' compensation insurance. None of a party's employees,
agents, or associates are employees the other party and each party agrees to
defend, indemnify and hold the other harmless from any and all claims made by
any of its employees, agents, or associates, or by any entity or agency on
account of an alleged failure to satisfy any such tax or withholding
obligations. Neither party has authority to act on behalf of or to enter into
any contract, incur any liability, or make any representation on behalf of the
other.

17.  MISCELLANEOUS.

     17.1  Extraordinary Events.  In the event BBDC's delivery or arranging for
           --------------------
delivery of Products under this Agreement is prevented, impaired, reduced or
restricted by reason of force majeure, labor disputes, fire, acts of God, or any
other similar or dissimilar cause beyond its control, including but not limited
to the unavailability of such Products, transportation, shortage of materials or
fuel, delay in delivery or failure to deliver by BBDC's suppliers, loss of
facilities of distribution, the voluntary foregoing of the right to acquire or
use any materials in order to accommodate or comply with the orders, requests,
regulations, recommendation or instructions of any governmental authority
(whether in furtherance of national defense or war activities or to meet any
other emergency), or the compliance with any law, order, ruling, regulation,
instruction or requirements of any governmental authority or any political
subdivision or agency thereof, or for any other cause whether of the same or
different character than specified in this Agreement, beyond the reasonable
control of the affected party, BBDC, without liability or obligation, may

                                       14
<PAGE>

reduce or eliminate Products during the period of any such disability. In any
such case, Products that BBDC is unable to supply will be eliminated from this
contract by written notice describing the amounts eliminated and the estimated
time period during which deliveries are to be suspended; and BBDC will be
relieved of any liability with respect to such Products during the time BBDC may
be unable to deliver such Products.

     17.2  Severability.  In the event that any provision in this Agreement is
           ------------
held to be invalid, unenforceable, void or illegal, in whole or in part, by any
court of competent jurisdiction, it will be deemed severable from the remainder
of this Agreement and will in no way affect, impair or invalidate any other
provision in this Agreement.  If such provision will be deemed invalid due to
its scope or breadth, such provision will be deemed valid to the extent of the
scope of breadth permitted by law.

     17.3  Governing Law, Choice of Forum and Time for Bringing Action.  The
           -----------------------------------------------------------
validity, construction and performance of this Agreement will be governed by and
construed in accordance with the internal laws of the State of California
without regard to its choice of laws provisions and, if applicable, the laws of
the United States.  In the event any legal action is necessary to enforce or
interpret the terms of this Agreement, the parties agree that such action will
be brought in Superior Court for the State of California, and the parties hereby
submit to exclusive jurisdiction of such courts.  Each party further agrees that
personal jurisdiction over it may be effected by service of process by
registered or certified mail, return receipt requested, and that when so made
will be as if served upon it personally within the State of California.  Any
action for a breach of this Agreement must commence within two (2) year after
the cause of action has accrued.

     17.4  Entire Agreement.  This Agreement and all exhibits and schedules and
           ----------------
related agreements incorporated by reference constitute the complete agreement
between IR and BBDC with respect to the subject matter of this Agreement and
replace and supersede all prior written and oral agreements or statements by and
among the parties concerning the subject matter.  No representation or warranty
concerning the subject matter not contained in this Agreement will be binding on
the parties or have any force or effect whatsoever.

     17.5  Amendments.  This Agreement may not be amended, modified or waived in
           ----------
any respect without further written agreement of both parties, signed by their
respective authorized representatives.

     17.6  Counterparts.  This Agreement may be executed in one or more
           ------------
counterparts, which will together constitute but one and the same instrument.

     17.7  Waivers.  Neither party's failure to insist, in one or more
           -------
instances, upon the performance of any term of this Agreement will be construed
as a waiver or relinquishment of its right to such performance or other
performance of such term, and the other party's obligations will continue in
full force. Either party's consent to any act by the other party on any one
occasion will not be deemed a consent of the same act on any other occasion.

     17.8  Time Is of the Essence.  Time is of the essence in each provision of
           ----------------------
this Agreement.

     17.9  Captions.  The captions and heading in this Agreement are for
           --------
convenience only and will not affect in any way the meaning or interpretation of
this Agreement.

     17.10 Assignment.  Neither party may assign any rights or delegate any
           ----------
duties under this Agreement without the prior written consent of the other
party, which will not be unreasonably withheld or delayed, which consent will be
based on the financial capability and business reputation of the proposed
assignee, or in the case of IR, a proposed assignment to any affiliate of a
major national pharmaceutical wholesale distributor that competes with BBDC.
Notwithstanding the foregoing, IR acknowledges that BBDC has affiliates and
subsidiaries and may assign performance of some or all of the terms of this
Agreement to one or more such related entities.  For purposes of this Section,
any transfer, sale, merger or consolidation of IR, or a substantial portion of
IR's assets, whether by contract or operation of law, or

                                       15
<PAGE>

any other transaction or series of related transactions transferring all or
substantially all of IR's business, assets (including this Agreement), stock or
control will be deemed an assignment and require such prior written consent by
BBDC, but will not modify, supplement or terminate the rights or obligations of
the parties under this Agreement. For purposes of the preceding sentence,
"control" means, with respect to a corporation or limited liability company, the
right to exercise, directly or indirectly, more than fifty percent (50%) of the
voting rights attributable to the controlled corporation or limited liability
company and, with respect to any individual, partnership, trust, other entity or
association, the possession, directly or indirectly, of the power to direct or
cause the direction of any management or policies of the controlled entity.
Subject to the foregoing, the provisions of this Agreement will be binding upon
and will inure to the benefit of the successors and assigns of the respective
parties, including without limitation any partnerships, corporations, or other
entities in which the parties may have a controlling interest or position.
Except as expressly provided, this Section will not be construed as a consent by
either party to an assignment of this Agreement or any interest in it by either
party.

     17.11 Further Assurances.  Each party, at its own cost and expense, and at
           ------------------
the reasonable request of the other party, agrees to undertake all such further
acts and to execute all such further documents as may be necessary and
reasonably requested by either party to effectuate the performance of this
Agreement in accordance with the parties' intentions.

     17.12 Affiliate Companies.  In order to better serve the needs of IR,
           -------------------
Products may, from time to time, be provided by an affiliate company of BBDC.
IR hereby acknowledges this fact and expressly consents to this distribution
arrangement.  IR further agrees to be liable for all payments due under this
Agreement to any such affiliate.

     17.13 Interpretation.  In the event of any claimed conflict, omission or
           --------------
ambiguity in this Agreement, no presumption or burden of proof or persuasion
will be implied by virtue of the fact that this Agreement was prepared by or at
the request of a particular party.  This Agreement will be interpreted equally
as to both parties and not against the party that drafted it.  Whenever the
context requires, the gender of all words will include the masculine, feminine
and neuter, and the number of all words will include the singular and plural.
The word "and" includes the word "or".  The word "or" is disjunctive but not
necessarily exclusive.

     17.14 Parties in Interest.  Nothing in this Agreement will confer any
           -------------------
rights on any third parties other than IR and BBDC and their respective
successors and assigns, nor will any provision give any third person any right
of subrogation or action over or against any party to this Agreement.

     17.15 Information Reviewed.  IR has received and reviewed all information
           --------------------
it considers necessary or appropriate for deciding whether to purchase Products
from BBDC.  IR has had an opportunity to ask questions and receive answers from
BBDC regarding the terms of the purchase of the Products and has further had the
opportunity to obtain all information which it deems necessary to evaluate the
purchase of the Products and to verify the accuracy of information otherwise
provided to IR by BBDC.

     17.16 Reliance on Authority of Person Signing Agreement. Neither IR nor
           -------------------------------------------------
BBDC will be required to determine the authority of the individual signing this
Agreement to make any commitment or undertaking on behalf of such entity or to
determine any fact or circumstance bearing upon the existence of the authority
of such individual.

     17.17 Attorneys' Fees.  In the event that any dispute between IR and BBDC
           ---------------
should result in litigation, arbitration, or mediation the prevailing party in
such dispute will be entitled to recover from the other party all reasonable
fees, costs and expenses of enforcing any right of the prevailing party,
including reasonable attorneys' fees and expenses, all of which will be deemed
to have accrued upon the commencement of such action and will be paid whether or
not such action is prosecuted to judgment.  Any judgment or order entered in
such action will contain a specific provision providing for the recovery of
attorneys' fees and costs incurred in enforcing such judgment and an award of
prejudgment interest from

                                       16
<PAGE>

the date of the breach at the maximum rate of interest allowed by law.
"Attorneys' fees" include (1) post-judgment motions; (2) contempt proceedings;
(3) garnishment, levy, and debtor and third party examinations; (4) discovery;
and (5) bankruptcy litigation. "Prevailing party" means the party who is
determined in the proceeding to have prevailed or who prevails by dismissal,
default or otherwise.

     17.18 Notices.  All notices must be given in writing and be personally
           -------
delivered or delivered by facsimile or by certified or registered mail, return
receipt requested, postage prepaid, addressed to the parties as set forth
opposite their respective names below:

     IR:                 To the address set forth on the cover page of this
                         Agreement.

     BBDC:               Bergen Brunswig Drug Company
                         4000 Metropolitan Drive
                         Orange, CA 92868
                         Attn: Vice President, eCommerce Sales & Marketing
                         Fax: (714) 385-6826

     with a copy to:     Bergen Brunswig Corporation
                         4000 Metropolitan Drive
                         Orange, CA  92868
                         Attn: Executive Vice President,
                         Chief Legal Officer & Secretary
                         Fax: (714) 978-1148

     Items delivered personally will be deemed delivered on the date of actual
delivery.  Items sent electronically or by facsimile will be deemed delivered on
the first business day after the date of transmission.  Items sent by certified
or registered mail will be deemed delivered three (3) business days after
mailing.  A party may change the foregoing information or notices by notifying
the other party of such change in writing in accordance with the foregoing.

                         [END OF TERMS AND CONDITIONS]

                                       17
<PAGE>

                                   EXHIBIT 2
                                      TO
                         PRESCRIPTION PHARMACEUTICALS
                    INTERNET FULFILLMENT SERVICES AGREEMENT

                     PRESCRIPTION PHARMACEUTICALS ADDENDUM

1.   PRODUCTS AND TERRITORY.

     1.1  Products.  Section 1.1 of Exhibit 1 is hereby deleted and superseded
     by Section 2 of the cover page of this Agreement.

     1.2  Territory.  Notwithstanding Section 1.3 of Exhibit 1, MM will provide
     fulfillment services for prescription Products shipped only to consumers
     located in a jurisdiction to which MM is authorized to dispense and deliver
     prescription Products (the "MM Territory").  The MM Territory as of the
     date this Agreement is signed is set forth in Schedule 1.3-A to Exhibit 1.

     1.3  [**]

     1.4  Medi-care/Medicaid Services. The parties acknowledge and agree that MM
     will not be required to dispense pursuant to any Medicare or Medicaid
     programs under this Agreement and IR may contract with other providers for
     such services.  Should IR consider doing so, it will provide MM Notice
     pursuant to Section 1.5 of Exhibit 1, including either a copy of the
     proposed contract or a written summary of its relevant terms including
     pricing.  If MM wishes to match such terms, it will notify IR within thirty
     (30) days of MM's receipt of the Notice and enter into an amendment to this
     Agreement with IR with respect to such services within ninety (90) days of
     its receipt of the Notice.  Otherwise, IR may enter into an agreement
     immediately thereafter with a third party for such services on terms and
     conditions no less favorable to IR than those in the Notice.

     1.5  In the event IR identifies new Products or obtains more favorable
     pricing on existing Products, MM will request that its distributor stock
     such Products, subject to the supplier of such Products complying with the
     distributor's standard procurement approval process, including meeting its
     standard requirements for suppliers.

2.   SHIPPING AND LABELS.

     2.1  Shipping.  Notwithstanding Section 2.4 of Exhibit 1, MM will ship all
     Products to IR's consumers prepaid and will bill IR for such shipping
     charges, including any volume discount normally given to MM by IR's
     shipper.

     2.2  Title to Prescription Products.  The fourth (4/th/) sentence of
     Section 2.4 of Exhibit 1 is amended to read: "Title to, and risk of loss
     of, all Products for purposes of payment will pass from MM to IR upon MM's
     delivery of the Products to the shipper for delivery to IR's

                                              **Confidential treatment has been
                                              requested with respect to the
                                              information contained within the
                                              "[**]" markings. Such marked
                                              portions have been omitted from
                                              this filing and have been filed
                                              separately with the Securities and
                                              Exchange Commission.

                                       18

<PAGE>

consumer."

     2.3  Labels.  Notwithstanding Section 2.5 of Exhibit 1, MM and IR will
     jointly develop, at IR's cost, standard packaging labels and invoice forms
     bearing both MM's and IR's name, logo and telephone number, if permitted or
     required by applicable federal or state law, for MM's use in shipping the
     Products.  The last two sentences of Section 2.5 are deleted.

3.   PRICING; PAYMENT.

     3.1  Pricing Protocol. [**]

     3.2  Taxes.  Notwithstanding Section 3.4 of Exhibit 1, IR will obtain and
     maintain a resale tax certificate in Nevada in addition to any other such
     certificates.

     3.3  Timing of Payment.  [**]

     3.4  Reimbursement.  To the extent required by third party payers or
     applicable law, reimbursement for Product will be directly to MM.

4.   IR'S COVENANTS.

     4.1  Web Site.  Notwithstanding Section 4.1 of Exhibit 1, each screen
     applicable to dispensing prescription Products and accessible to consumers
     through IR's web site will clearly identify MM as the dispensing pharmacy.

     4.2  Consumer Enrollment.  Notwithstanding Section 4.3 of Exhibit 1, IR
     will not collect consumer prescriptions nor dispense any prescription
     Products.

     4.3  Patient Confidentiality.  Notwithstanding Section 4.4 of Exhibit 1, MM
     is obligated pursuant to Section 5.4 of Exhibit 1 to maintain and protect
     the confidentiality of all confidential patient information and records,
     including protected health care information, and pursuant to Section 14.1
     of Exhibit 1, IR hereby indemnifies MM for any Claim arising from any
     unauthorized use of protected confidential patient information or its
     unauthorized re-disclosure to any person not bound by ethical and legal
     obligations to protect its confidentiality and use.  "Protected health care
     information" is any information or data, whether oral or recorded in any
     form, that identifies or can be readily associated with an identifiable
     patient or other record subject and (i) relates to a patient's health care
     or (ii) is obtained in the course of a patient's health care from a health
     care provider, including MM, from the patient, from a member of the
     patient's family or an individual with whom the patient has a close
     personal relationship or from the patient's legal representative.  The
     definition of "Confidential Information" under Section 11.1 of Exhibit 1 is
     hereby amended to include protected health care information and any
     protected confidential patient information under all applicable federal and
     state laws.

     4.4  Adverse Event Reporting.  Notwithstanding Section 4.9 of Exhibit 1,
     each party will report all adverse events relating to the Products pursuant
     to the requirements of the Food and Drug Administration.

     4.5  Pharmacist Support.  In connection with pharmacist support and
     customer service, IR will develop and maintain on its web site consumer
     accessible electronic information,

                                              **Confidential treatment has been
                                              requested with respect to the
                                              information contained within the
                                              "[**]" markings. Such marked
                                              portions have been omitted from
                                              this filing and have been filed
                                              separately with the Securities and
                                              Exchange Commission.

                                       19

<PAGE>

     including frequently asked questions (FAQs) and other information that will
     minimize routine consumer inquires to MM's pharmacist support and customer
     service desk.

5.   REPRESENTATIONS OF THE PARTIES.

     5.1  Licenses.  MM represents that it holds valid pharmacy licenses for
     each location from which it will operate during the Term and that these
     licenses permit it to dispense and deliver the Products to consumers with
     valid prescriptions in the MM Territory.

     5.2  NCPDP Number.  MM will utilize its identification number ("NCPDP
     Number") issued by the National Association of Boards of Pharmacy ("NABP")
     for adjudicating and filling prescription Products to IR's consumers.

6.   SOFTWARE AND DATABASE LICENSE.

     Section 7 of Exhibit 1 is hereby deleted in its entirety.

7.   NOTICES.

     Notwithstanding Section 17.19 of Exhibit 1, MM's address is:

                      Medi-Mail, Inc.,
                      871-C Grier Drive
                      Las Vegas, Nevada 89119
                      Attn:  Chairman & CEO
                      Fax: (702) 361-2422

     with a copy to:  Bergen Brunswig Corporation
                      4000 Metropolitan Drive
                      Orange, CA 92868
                      Attn:  Executive Vice President,
                      Chief Legal Officer & Secretary
                      Fax:  (714) 978-1148

                                       20<PAGE>

                                                                   EXHIBIT 10.13

                   Service Mark License and Access Agreement
                   -----------------------------------------

     This Service Mark License and Access Agreement ("Agreement") is made as of
this 18/th/ day of August, 1999 ("Effective Date"), between more.com, Inc., a
Delaware corporation ("Licensee") and Bergen Brunswig Drug Company, a California
corporation ("Licensor").

     1.   License to Service Marks.  Licensor hereby grants to Licensee, during
          ------------------------
the term of the Internet Fulfillment Services Agreement dated July 1, 999
between the parties ("Fulfillment Agreement"), unless sooner terminated in
accordance with this Agreement, a non-exclusive, revocable (as expressly set
forth herein) license ("License") for the use of the Service Marks "Good
Neighbor", "Good Neighbor Pharmacy" and "PlusCare", and their associated
goodwill, which Licensor owns (collectively, "Licensed Marks") solely in
connection with Licensee's business, subject to the terms and conditions
contained in this Agreement on a royalty-free basis.  Licensee acknowledges that
Licensor is the owner of all proprietary rights in and to the Licensed Marks and
that Licensee acquires no right, title or interest in and to the same
whatsoever, other than the right to use the Licensed Marks in accordance with
the terms of this Agreement.  Licensee will immediately notify Licensor in
writing of any infringement or limitation of the Licensed Marks that may come to
Licensee's attention.

     2.   Quality Specifications.  Since the activities of Licensee will reflect
          ----------------------
on the Licensed Marks, Licensee will operate its business with diligence and
vigor, will maintain the highest possible ethics and will maintain its
operations in a manner that will reflect the high standards and quality
attributable to the Licensed Marks.  Licensee will fully comply in all material
respects with all laws, rules and regulations applicable to Licensee's business
and the conduct thereof.  Except as otherwise set forth in this Agreement,
Licensee will use the Licensed Marks only in accordance with Licensor's
reasonable specifications regarding the Licensed Marks, including without
limitation, specifications concerning standards of quality, use, advertising and
promotion, as such specifications may be modified from time to time in the sole
discretion of Licensor but on reasonable prior notice to Licensee before
Licensee is required to comply ("Quality Specifications"). If at any time
services provided by Licensor fail to conform to the Quality Specifications,
Licensor will so notify Licensee of such non-conformance.  Upon such
notification, Licensor will promptly cease the services provided by it which do
not adhere to the Quality Specifications, until such time as the standards of
quality contained in the applicable Quality Specifications have been met to the
reasonable satisfaction of Licensor.

     3.   Conditions Applicable to Appearance of Licensed Marks.
          -----------------------------------------------------

          (a) Use Specifications.  Licensee will comply with conditions set
              ------------------
forth in any prior written notice provided to Licensee from time-to-time by
Licensor with respect to the style, appearance and manner of use of the Licensed
Marks ("Use Specifications"). Any use of the Licensed Marks not specifically
provided for by such Use Specifications

                                       1
<PAGE>

will be adopted by Licensee only upon prior written approval of Licensor not to
be unreasonably withheld or delayed. In addition, Licensor may request that
notices reasonably acceptable to Licensor be used on or with Licensee's services
and marketing materials (which marketing materials are subject to Licensor's
prior written consent, which consent will not be unreasonably withheld) bearing
the Licensed Marks to identify the licensed use under this Agreement.

          (b) Co-Branding.  All future marketing activities by Licensee may,
              -----------
upon the express agreement of the parties, feature a co-branded service mark
agreeable to the parties. Licensee will seek approval from Licensor, which
approval may not be unreasonably withheld or delayed, prior to (i) launching any
online or offline advertising or marketing campaign using the Licensed Marks, or
(ii) posting any Good Neighbor Pharmacy related material on Licensee's web site,
or other advertiser web sites.

          (c) Licensor's Approval.  In addition, prior to any application of the
              -------------------
Licensed Marks to any of Licensee's related marketing materials (as permitted
under this Agreement), Licensee will provide any samples of such marketing
materials (including web site designs) to Licensor for final review and
approval, such approval to be not unreasonably withheld or delayed.  Marketing
material which uses any of the Licensed Marks or which refers to Licensor or any
parent or other affiliate of Licensor will conform to the Use Specifications, as
amended from time to time on prior written notice to Licensee.  All such
Licensee-initiated marketing material is expressly subject to prepublication
review and approval not to be unreasonably withheld or delayed with respect to,
but not limited to, content, style, appearance, composition, timing, and media.
One copy of all such marketing material will be provided to Licensor at least
thirty (30) days prior to anticipated publication.  The parties acknowledge and
agree, however, that Licensee will not be required to seek the prior approval of
Licensor in connection with the day-to-day operation of the Licensee web sites,
and changes thereto, provided that the operations of the web sites at all times
substantially comply with the then-current Use Specifications and any other
relevant policies or designs pre-approved by Licensee pursuant to this
Agreement.

     4.   Protection of Licensed Marks.
          ----------------------------

          (a) Validity.  Licensee admits the validity of, and agrees not to
              --------
challenge the Licensed Marks. Licensee also agrees that any and all rights that
may be acquired by the use of the Licensed Marks by Licensee will inure to the
sole benefit of Licensor. Licensee agrees to execute all papers reasonably
requested by Licensor at Licensor's expense to effect the recording of Licensee
as a registered user of the Licensed Marks. Licensee may not use any of the
Licensed Marks or any part thereof as part of its corporate name nor use any
name or mark confusingly similar to the Licensed Marks.

          (b) Confusing Marks.  Licensee further agrees not to register in any
              ---------------
country any name or mark resembling or confusingly similar to the Licensed
Marks.  If any application for registration is or has been filed in any country
by Licensee which relates

                                       2
<PAGE>

to any name or mark which, in the sole opinion of Licensor, is confusingly
similar, deceptive or misleading with respect to any of the Licensed Marks,
Licensee will immediately abandon any such application or registration or, at
Licensor's sole discretion, assign it to Licensor. Licensee will reimburse
Licensor for all reasonable costs and expenses of any opposition, cancellation
or related legal proceedings, including attorney's fees, instigated by Licensor
or its authorized representative, in connection with any such registration or
application.

          (c) Third Party Infringement.  In the event that Licensee learns of
              ------------------------
any infringement or threatened infringement of the Licensed Marks or any
passing-off or learns that any third party claims any Licensed Mark is liable to
cause deception or confusion to the public, Licensee will promptly notify
Licensor, giving particulars and providing necessary information and assistance
to Licensor at Licensor's expense in the event that Licensor decides that
proceedings should be commenced or defended. Any such proceedings will be at
Licensor's expense and any recoveries will be Licensor's sole property. Nothing
in this Agreement, however, will be deemed to require Licensor to enforce the
Licensed Marks against others.

          (d) Compliance with Laws.  In addition to Licensee's compliance with
              --------------------
all laws and regulations applicable to Licensee's performance of this Agreement,
Licensee will comply in all material respects with all laws applicable to proper
use and designation of trademarks and service marks in the countries in which
Licensee uses the Licensed Marks. If Licensee becomes aware of any laws
applicable to Licensed Marks that are inconsistent with this Agreement, Licensee
will promptly notify Licensor of such inconsistency. Licensor may, at its
option, either waive the performance of such inconsistent provisions or
terminate the license and rights granted under this Agreement to the extent in
conflict with such laws.

     5.   No Assignment or Sublicense.  The benefit of the service mark licenses
          ---------------------------
granted under this Agreement are personal to Licensee and Licensee may not,
without the prior written consent of Licensor, assign the Licensed Marks, nor
part with any of its rights or obligations under this Agreement, nor grant or
purport to grant any sublicense in respect to the Licensed Marks.

     6.   Term and Termination of License.
          -------------------------------

          (a) Term.  Unless sooner terminated in accordance with the terms of
              ----
this Agreement or the Fulfillment Agreement, the service mark license granted
under this Agreement will commence on the Effective Date and will continue in
effect for the duration of the Fulfillment Agreement, including any extensions
and renewals. Notwithstanding any provision of this Agreement to the contrary,
this Agreement will immediately terminate upon termination or expiration of the
Fulfillment Agreement.

          (b) Rights Upon Termination.  Upon termination or expiration of the
              -----------------------
licenses and rights granted under this Agreement, by operation of law or
otherwise, all rights (including the right to use the Licensed Marks),
privileges and obligations arising under

                                       3
<PAGE>

this Agreement (except the obligations in Section 4) will cease to exist and
Licensee will immediately discontinue completely all further use of the Licensed
Marks.

          (c) Material Breach.  In the event of a material breach of this
              ---------------
Agreement by either party, the non-breaching party may terminate this Agreement
upon thirty (30) days written notice to the breaching party and such termination
will be effective on the thirty-first (31st) day after receipt of an express
written notice of breach if (a) the breaching party does not correct such
material breach within such thirty (30) day cure period, or (b) in the case of a
material breach that is correctable but is not reasonably capable of being
corrected within such thirty (30) day cure period, the breaching party does not
take reasonably practicable steps to correct such breach and to prevent a
recurrence. The following will be considered to be material breaches:

              1.  Licensee using any trademarks, services marks, trade or
                  business names contrary to the provisions of this Agreement;
                  or

              2.  Licensee offering services bearing any of the Licensed Marks
                  in which such service fails in a material fashion to meet any
                  of the standards set forth in the applicable Quality
                  Specifications or Use Specifications; or

              3.  Licensee refusing or neglecting any request by Licensor for
                  marketing materials, advertising copy, stationary or other
                  materials as provided under this Agreement; or

              4.  Licensee using the Licensed Marks with services or on
                  marketing materials or referencing Licensor or its parent or
                  other affiliates, without conforming to Licensor's written
                  instructions; or

              5.  Licensee assigning or purporting to assign any of the rights
                  granted in this Agreement to others without Licensor's express
                  prior written consent.

     7.   Certain Representations and Covenants.  Licensor is the true and
          --------------------------------------
lawful owner of and has the right to use and license the Licensed Marks.
Licensor has no knowledge of any third party claim to the effect that any aspect
of the Licensed Marks infringes any other trademark, service mark or trade name.
The Licensed Marks are registered in the U.S. Patent and Trademark Office and
such registrations are valid, subsisting and have not been cancelled and are
registered in the categories/classes shown in Exhibit A.

     8.   Networks Access.
          ---------------

          (a) Access.  Licensor will provide Licensee with access to Licensor's
              ------
network of independently owned and operated Good Neighbor Pharmacies and
"PlusCare" network and the covered lives in the PlusCare network to facilitate
the ordering, adjudication, if applicable, and in-store pick up of prescription
medicine by the Licensee's consumers ("GNP/PlusCare Access").  The parties will
work together in

                                       4
<PAGE>

good faith to provide for GNP/PlusCare Access and to pursue the resolution of
any logistical issues with respect to the integration with Licensee's web site
and e-commerce services.

              1.  GNP & Pharmacy Access.  Specifically, Licensor will work to
                  ---------------------
                  make available and create on an as-needed basis the ability
                  for Licensee to accept and fulfill orders for prescription
                  products through GNP and PlusCare pharmacies, with a consumer
                  able to pick-up such an order within [**] or, if such service
                  is available from the local pharmacy, to have it delivered
                  locally. Licensor will be Licensee's exclusive pharmaceutical
                  provider for such services and, in the event Licensee proposes
                  a specific need for similar services from additional locations
                  or from stores with different capabilities, Licensor will have
                  thirty (30) days from receipt of such specific criteria to
                  propose a plan to meet such need. If Licensor's proposed plan,
                  including proposed timelines, does not reasonably meet
                  Licensee's needs, Licensee may utilize alternate resources. In
                  providing such services, the parties will strive for the
                  broadest possible national coverage.

              2.  Managed Care Organization Access.  The parties will work
                  --------------------------------
                  diligently to develop a strategic business plan to expand
                  beyond Licensor's current PlusCare network participation by
                  managed care organizations ("MCO"), including insurers, third
                  party payers, healthcare maintenance organizations (HMOs),
                  pharmaceutical benefit managers (PBMs), third party
                  administrators (TPAs), pharmaceutical service administrative
                  organizations (PSAOs), employers, coalitions and others. The
                  parties will designate specific resources to develop such
                  strategic plan. The plan will identify specific geographic
                  areas, demographic groups and types of MCOs to target, will
                  delegate specific actions between the parties and will set
                  goals and timelines. The parties will jointly implement the
                  plan, including presentations, bid responses and proposals,
                  and RFP responses and Licensor will be Licensee's exclusive
                  provider for such implementation with MCOs. Licensee will
                  coordinate all such interactions with Licensor and will not
                  enter into any agreements with MCOs without Licensor's prior
                  written consent. In the event Licensee identifies a need for
                  new or additional services for an existing MCO or the need to
                  establish a relationship with a new MCO, Licensor will have
                  sixty (60) days from receipt of such specific criteria to
                  propose a plan to meet such need. If Licensor's proposed plan,
                  including proposed timelines, does not reasonably meet
                  Licensee's needs, Licensee may utilize alternate resources.

          (b)  Representations.  Licensor's Good Neighbor Pharmacy
Network has 4,000 independent pharmacies (more than 1,800 Level I and 2,500
Level II Stores) and Licensor's PlusCare Provider Network has approximately 75
million PBM covered

                                              **Confidential treatment has been
                                              requested with respect to the
                                              information contained within the
                                              "[**]" markings. Such marked
                                              portions have been omitted from
                                              this filing and have been filed
                                              separately with the Securities and
                                              Exchange Commission.

                                       5
<PAGE>

lives. Licensor will not grant GNP/PlusCare Access to certain of Licensee's
competitors for a period ending August 17, 2000. Such competitors are Rx.com,
Soma.com and Drugstore.com and, until September 30, 1999, to PlanetRx.com.

     9.   Notices.  Any notices must be in writing and will be valid if sent by
          -------
registered or certified mail, postage prepaid, in any post office in the United
States, or by confirmed facsimile, hand delivery or overnight courier, addressed
as follows:

If to Licensor:                       With a Copy to:
--------------                        --------------
Bergen Brunswig Drug Company          Bergen Brunswig Corporation
4000 Metropolitan Drive               4000 Metropolitan Drive
Orange, CA 92868                      Orange, CA 92868
Attn:  E.V.P. Sales & Marketing       Attn:  E.V.P., Chief Legal Officer
Facsimile: (714) 385-8879             & Secretary
                                      Facsimile: (714) 948-1148

If to Licensee:
--------------
more.com, Inc.
520 Third Street, Suite 245
San Francisco, California 94107
Attn: Brad Oberwager
Facsimile: (415) ____________

     All notices sent by confirmed facsimile will be deemed to be effective on
the date of transmission.  All notices sent by courier will be deemed to be
effective on the date of receipt or refusal.  In case either party changes its
address to which notice is to be received, written notice of such change will be
given without delay to the other party.  Notice may be given by any authorized
representative including counsel.

     10.  Section Headings.   The headings as to the contents of particular
          ----------------
Sections are for convenience only and are in no way to be construed as part of
this Agreement or as a limitation of the scope of the particular Sections to
which they refer.

     11.  Entire Agreement.  This Service Mark License and Access Agreement,
          ----------------
together with the Quality Specifications and Use Specifications, constitutes the
entire agreement between the parties with respect to its subject matter and
merges and supersedes all previous communications, warranties, representations,
and agreements, oral or written, between the parties with respect to such
subject matter.  No amendment or modification of this Agreement will be binding
on either party unless reduced to writing and duly executed by an authorized
representative of both parties.  Failure to enforce or any delay in enforcing
any right under this Agreement by any party will not be construed as a waiver
nor will it be deemed a waiver of any other right such party may otherwise have
at law or in equity.

                                       6
<PAGE>

     In Witness Whereof, this Agreement has been executed on behalf of each of
the parties by their duly authorized representatives as of the Effective Date.

                              Bergen Brunswig Drug Company

                              By:  /s/ Brent Martini
                                 ----------------------------------------------

                              more.com, Inc.

                              By: /s/ Laureen De Buono
                                 ----------------------------------------------

                                       7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00001-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00001-of-00352.parquet"}]]